TSS:Hg 13799.1

Basic information about the TSS

---

TSS ID: hg_13799.1 Species: human Chr: chr1		Start: 111140151 End: 111140168 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000484310.5 uc057jgo.1 Distance: -35 GeneID: 128338 HGNC/MGI_ID: HGNC:28769 UniProt_ID:

Gene_name: DNA damage regulated autophagy modulator 2 Gene_symbol: DRAM2 Gene_synonyms: MGC54289 PRO180 RP5-1180E21.1 WWFQ154 Gene_source: HGNC:28769

TATA-Box annotation

---

Distance to TSS:	-3
Nearest PromoterID:	NR_138484
Entrez ID:	10390
Nearest Unigene:	Hs.363572
Nearest Refseq:	NM_006090
Nearest Ensembl:	ENSG00000134255
Gene Name:	DNA damage regulated autophagy modulator 2
Gene Alias:	-
Gene Description:	choline/ethanolamine phosphotransferase 1
Gene Type:	protein-coding
CpG%:	0.135
GC%:	0.696517
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DRAM2 p2@DRAM2 p3@DRAM2 p4@DRAM2 p5@DRAM2 p7@DRAM2 p8@DRAM2
Sample		p1@DRAM2	p2@DRAM2	p3@DRAM2	p4@DRAM2	p5@DRAM2	p7@DRAM2	p8@DRAM2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	15.00	0.78	0.97	0.39	0.39	0.00	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	17.60	1.01	0.81	0.00	0.20	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.80	0.96	1.16	0.19	0.00	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	15.80	0.42	0.21	0.21	0.00	0.00	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.50	0.90	0.67	0.22	0.00	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.86	0.78	0.78	0.00	0.58	0.00	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	24.40	1.09	0.87	1.31	0.65	0.00	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	17.44	0.97	0.73	0.24	0.73	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	19.45	0.85	1.50	0.00	0.00	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	30.14	0.58	2.32	0.00	1.16	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	25.47	1.62	0.81	0.40	1.62	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	29.27	0.41	0.81	0.41	2.03	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	17.57	4.51	1.61	1.93	0.16	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	24.21	3.01	1.65	1.20	0.45	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	17.56	2.42	0.88	0.88	0.88	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.86	1.76	1.51	1.51	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	21.84	1.97	0.87	1.75	0.87	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	12.23	2.95	0.84	0.84	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	18.13	2.13	0.53	1.07	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	18.96	3.01	1.65	1.96	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.98	2.67	1.34	2.00	1.07	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	22.61	3.28	0.69	1.55	1.04	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	17.19	1.55	1.03	1.55	0.26	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.99	1.70	0.97	0.73	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.38	2.84	1.03	1.55	0.26	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.19	2.85	1.27	1.27	0.63	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.28	1.10	1.10	2.20	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	22.16	3.06	2.59	1.41	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.16	2.26	2.26	1.13	0.81	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	19.73	2.90	1.27	1.99	0.18	0.00	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.33	3.14	1.05	1.26	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.98	1.95	1.95	1.56	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	15.62	2.74	2.32	2.32	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.73	4.12	1.65	1.48	0.49	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.38	2.62	0.93	2.43	0.75	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.25	3.45	1.15	1.34	1.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.94	3.68	1.43	1.64	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.69	2.42	1.81	1.01	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.18	2.97	1.62	1.08	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.32	2.16	1.20	0.96	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.76	3.06	1.18	0.71	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	18.45	3.22	1.32	0.88	0.44	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.14	2.32	0.42	1.27	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.99	2.97	0.52	0.70	0.87	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.26	1.61	2.01	2.21	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.35	1.40	0.93	0.93	0.23	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	16.55	2.64	0.72	0.72	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.20	2.09	1.79	2.09	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	12.45	2.39	0.72	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.95	2.02	1.01	0.81	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.35	2.66	1.84	1.84	0.61	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	17.35	2.22	1.56	1.33	0.44	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	97.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.13	1.42	0.35	1.06	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	16.24	1.33	1.99	1.66	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	44.46	4.19	2.52	0.84	0.00	0.00	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	30.31	1.84	0.00	1.38	0.00	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.58	0.65	2.27	1.30	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.45	2.25	1.28	0.32	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	26.09	1.57	3.14	1.57	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	1.41	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.02	1.68	0.56	0.00	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.88	3.98	0.80	3.18	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	26.50	2.04	1.02	0.68	0.34	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.30	0.97	1.62	3.57	0.65	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.84	2.13	1.06	0.71	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00	0.00	0.00	145.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	15.79	0.00	0.00	47.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.60	2.44	2.44	1.46	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.37	2.98	0.50	1.49	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.67	3.28	2.81	3.28	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.51	6.29	3.31	3.31	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.78	4.02	4.33	2.17	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	10.40	7.03	1.83	0.92	0.92	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	27.40	3.48	2.38	1.43	0.48	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	24.55	5.78	2.73	2.73	0.48	0.00	0.48
Adipocyte - omental, donor1	11473-119C6	32.32	3.44	3.05	2.54	0.76	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	17.94	5.23	0.75	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	47.56	5.36	2.01	0.67	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	28.07	3.19	0.64	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	1.10	1.10	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.94	4.06	2.71	1.35	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	24.50	5.21	1.91	1.91	0.17	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	29.34	3.13	2.93	2.54	0.78	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	20.08	1.54	0.77	2.06	0.26	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	25.65	2.79	2.79	1.12	0.00	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	16.46	1.18	1.18	1.18	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.31	4.02	2.25	2.17	1.13	0.00	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	28.08	2.90	2.90	3.23	0.97	0.00	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	43.19	1.07	1.60	2.67	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	16.69	3.34	0.00	1.67	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	23.71	4.57	2.08	2.91	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	25.12	4.27	3.01	1.51	0.75	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	33.71	2.62	1.31	2.29	0.65	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	11.57	2.13	1.83	1.52	0.91	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	6.85	0.44	0.66	0.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.10	1.26	1.08	0.36	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.01	1.03	0.82	1.03	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	27.23	2.52	1.72	1.26	0.00	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	15.67	3.18	1.96	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.03	1.35	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.50	0.87	0.43	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	2.14	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	16.44	0.90	1.20	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	3.79	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.88	0.66	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.00	0.65	0.97	0.00	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.62	0.97	0.00	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.79	2.38	1.78	0.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.82	0.75	0.75	0.75	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	0.73	1.45	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	1.25	0.00	3.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	25.20	1.15	1.32	0.66	0.49	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	20.36	1.81	0.75	1.06	0.30	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	0.00	1.61	2.68	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	17.76	1.32	0.94	0.94	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.64	1.87	0.80	0.53	0.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	7.80	0.00	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.74	1.33	0.66	0.66	0.33	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	0.00	1.20	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	17.67	0.69	1.03	0.17	0.34	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	0.00	0.00	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	19.42	0.00	0.49	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.21	1.52	0.76	1.52	0.38	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	3.63	1.21	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	0.00	0.00	1.14	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.09	1.71	1.92	0.00	0.21	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	14.45	0.77	1.29	0.52	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	12.20	1.41	0.47	0.47	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.58	1.61	1.29	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	0.71	0.71	1.43	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.89	1.75	0.00	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.46	0.90	1.20	0.30	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	2.38	0.00	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.29	2.54	1.02	0.51	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.39	0.76	1.27	0.25	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.15	0.64	1.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	16.83	0.86	1.29	0.00	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.66	1.69	0.64	0.85	0.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.92	1.16	1.16	1.16	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	1.89	2.83	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.10	0.85	1.53	0.17	0.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	17.15	2.14	0.86	0.21	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	18.05	0.60	0.60	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.85	0.00	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	20.46	1.15	1.38	0.92	0.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	0.00	5.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	17.80	0.51	1.02	1.02	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	18.79	1.45	0.41	0.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.85	2.14	1.53	0.31	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.73	1.43	0.00	0.96	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.74	0.44	1.77	0.67	0.44	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	0.55	0.55	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.15	0.79	0.79	0.26	0.79	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.63	2.54	0.73	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	7.37	0.86	0.61	0.37	0.12	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	2.40	0.51	0.00	0.34	0.34	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	2.10	0.42	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	32.77	3.14	1.74	0.70	0.35	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	19.41	0.65	0.81	1.46	0.16	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	22.22	1.04	1.19	0.89	0.15	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	66.06	3.90	2.06	1.72	6.19	28.90	1.72
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	50.74	3.26	2.88	0.88	5.64	29.32	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	51.89	1.48	1.48	1.48	5.92	23.21	1.14
Basophils, donor1	12241-129G9	24.85	3.92	4.45	1.83	0.26	0.00	0.00
Basophils, donor2	12242-129H1	44.02	7.94	4.33	4.69	0.72	0.00	0.36
Basophils, donor3	12243-129H2	41.60	7.79	2.06	2.35	0.59	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	6.68	0.65	0.22	0.86	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	0.00	0.00	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	7.53	1.88	0.63	0.00	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.03	1.25	0.83	1.04	0.21	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	16.12	1.15	0.92	0.23	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	32.03	4.32	3.24	3.06	0.00	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	51.22	2.16	1.13	1.03	13.50	36.28	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	69.64	2.56	1.63	0.93	16.07	8.62	2.79
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	46.05	3.20	1.60	4.16	0.96	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	41.14	3.38	2.25	2.82	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	48.07	5.94	2.78	3.16	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	19.98	6.37	2.20	1.54	0.22	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	239.74	8.77	7.93	2.83	1.42	0.28	5.09
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	192.95	9.10	6.44	4.55	2.27	0.38	4.93
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	231.10	10.85	8.55	2.96	2.30	0.00	3.94
CD14+ monocytes - mock treated, donor1	11863-125A9	45.10	6.36	1.88	0.58	0.14	0.00	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	49.79	3.92	1.81	0.30	0.00	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	41.46	3.55	2.13	0.71	0.00	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	33.98	4.85	0.50	0.67	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	30.09	1.38	0.55	1.10	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	32.48	3.22	0.74	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	33.48	4.90	1.57	1.37	0.00	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	34.72	2.85	0.53	0.53	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	52.88	4.13	0.44	0.65	0.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	35.59	6.09	0.94	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	48.58	1.58	0.53	1.58	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	2.22	0.00	3.33	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	41.50	6.40	2.38	1.64	0.00	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	41.11	3.59	1.20	1.00	0.20	0.00	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	51.84	2.71	0.62	2.08	0.21	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	41.41	3.66	0.46	0.46	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	52.93	2.49	0.90	0.90	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	19.64	0.87	0.00	1.75	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	43.31	2.96	2.69	0.54	0.27	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	56.35	4.36	0.35	1.57	0.00	0.00	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	51.34	3.79	2.10	1.26	0.00	0.00	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	26.82	6.25	0.73	0.73	0.00	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	27.12	1.41	1.06	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	26.32	0.44	0.44	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	33.48	4.18	1.39	1.92	0.17	0.00	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	43.49	3.35	0.00	1.12	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	56.91	4.53	2.16	1.51	0.00	0.00	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	34.81	2.87	0.82	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	42.65	2.55	0.23	0.46	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	37.58	1.39	1.16	0.00	0.00	0.00	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	141.02	9.37	6.54	4.14	0.44	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	101.64	10.63	3.70	2.08	0.46	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	146.65	12.56	4.55	3.68	0.22	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	114.30	12.46	8.56	2.80	0.16	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	88.72	9.78	5.06	1.40	0.00	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	103.01	9.59	5.80	4.46	0.00	0.00	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	106.92	14.80	7.91	2.04	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	91.56	11.86	5.05	2.63	0.00	0.00	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	110.75	14.74	6.95	3.58	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	221.52	12.19	4.06	8.13	4.06	26.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	261.02	8.14	5.42	14.24	2.71	17.63	4.75
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	266.15	10.36	4.14	10.36	4.14	18.64	5.18
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	242.53	11.73	10.13	12.26	30.92	28.78	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	236.94	14.47	6.97	15.01	31.09	23.59	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	237.26	14.74	5.62	10.53	0.70	17.55	4.91
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	281.58	16.47	9.41	7.06	4.71	18.82	5.49
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	300.57	14.50	3.95	15.82	3.95	25.05	2.64
CD19+ B Cells, donor1	11544-120B5	130.68	9.86	4.11	8.22	12.33	4.93	0.82
CD19+ B Cells, donor2	11624-122B4	84.15	8.71	5.08	7.25	7.25	7.98	0.73
CD19+ B Cells, donor3	11705-123B4	116.61	8.58	5.05	6.06	11.11	6.56	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	18.18	2.83	2.42	2.42	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.99	6.39	2.00	2.80	0.00	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	45.18	2.01	2.01	2.01	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	66.86	6.18	0.56	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	49.22	2.63	3.38	3.01	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	57.50	4.06	3.83	4.06	0.45	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	23.21	10.00	1.43	8.57	1.43	0.00	1.07
CD4+ T Cells, donor2	11306-117C1	31.84	9.80	3.06	11.02	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	14.64	8.84	2.44	5.79	0.91	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	34.97	7.40	6.13	4.59	0.77	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	28.52	11.23	4.94	4.04	1.57	0.00	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	39.96	12.07	4.89	5.75	2.30	0.00	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	48.83	14.70	6.16	14.22	1.90	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.03	13.34	6.32	18.26	2.11	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	13.18	6.59	19.78	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	34.11	8.82	5.49	2.89	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	19.32	5.59	4.74	3.22	0.51	0.00	2.71
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.99	5.32	5.32	2.26	0.81	0.00	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	30.04	12.10	4.48	6.28	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	30.40	13.28	4.19	7.34	1.40	0.00	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.04	13.20	4.84	7.92	0.44	0.00	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	43.85	7.17	4.64	1.26	1.26	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	18.91	5.61	4.57	4.16	1.04	0.00	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.71	6.35	3.68	3.68	0.00	0.00	2.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	41.88	16.04	3.81	11.42	1.63	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	41.27	16.08	3.22	15.01	2.14	0.00	4.29
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	46.62	8.97	3.59	16.14	1.79	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.15	7.97	4.45	3.15	0.74	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.04	8.23	4.55	3.68	0.43	0.00	2.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.01	8.62	5.67	2.31	0.63	0.00	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	34.89	10.11	4.04	9.61	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	26.00	9.96	2.17	4.77	0.87	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	43.15	9.15	7.41	13.51	1.31	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	56.91	19.79	3.46	11.88	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	58.16	17.54	6.46	12.00	0.00	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	18.15	11.17	13.96	1.40	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	67.85	21.60	3.32	10.80	1.38	0.00	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	66.50	22.33	5.15	15.95	2.21	0.00	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	61.60	12.32	6.16	13.86	1.54	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	52.64	14.68	7.16	14.32	0.36	0.00	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	52.63	12.46	13.85	16.62	0.00	0.00	2.77
CD8+ T Cells, donor1	11226-116C2	18.99	4.91	1.64	3.93	0.98	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	14.64	6.38	0.75	6.38	0.00	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	17.17	7.83	2.02	8.84	1.26	0.00	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.80	1.38	0.46	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.39	1.44	1.44	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.58	1.09	0.55	1.09	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.01	2.40	0.90	0.00	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	9.36	0.48	1.44	0.24	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.00	1.14	1.14	0.45	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	9.78	0.22	0.87	0.43	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.37	1.05	1.32	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.55	0.94	1.17	0.23	0.23	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.58	0.60	1.51	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	10.46	1.16	1.16	0.29	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.39	1.60	2.93	0.53	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.07	1.75	1.31	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.47	1.82	0.00	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	0.75	1.49	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.89	0.72	0.72	0.72	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.66	1.44	0.29	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.96	0.94	0.24	0.94	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	10.46	3.17	1.27	0.63	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.92	2.46	1.85	1.23	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.18	1.28	0.96	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.27	1.53	1.53	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	10.25	0.79	0.79	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	13.62	0.76	3.03	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	27.30	2.41	2.41	2.41	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.98	4.20	2.10	0.00	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	5.01	2.00	0.00	2.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	3.66	0.00	0.00	5.48	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	18.28	2.47	1.98	0.99	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	23.47	1.47	1.58	1.16	0.11	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	24.96	2.08	1.39	2.77	0.35	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	14.93	2.84	1.78	1.42	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	26.17	2.50	2.28	1.25	0.23	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	32.23	3.58	1.79	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	23.86	2.02	0.40	1.62	0.40	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	27.08	1.72	1.72	1.38	0.80	0.00	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	14.54	0.86	0.43	0.43	0.43	0.00	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	17.52	1.15	0.62	0.88	0.27	0.00	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	21.09	2.20	2.66	2.02	0.18	0.00	0.28
Corneal Epithelial Cells, donor1	11526-119I5	3.73	0.66	0.44	0.44	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	3.41	1.14	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.90	0.77	0.77	0.00	0.00	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	62.57	4.46	2.31	0.50	1.98	0.00	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	69.07	2.84	5.05	1.26	1.89	0.00	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	0.00	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	57.02	4.64	5.18	1.51	0.11	0.00	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	64.57	2.73	2.05	2.73	4.78	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	86.18	7.18	1.31	5.88	5.88	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	74.04	7.74	1.45	4.36	3.87	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	10.17	0.50	0.33	0.17	0.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	0.00	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	7.92	1.13	0.85	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	0.79	0.39	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	9.60	0.58	0.58	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	8.00	0.71	0.94	0.24	0.00	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	9.64	1.58	1.23	0.70	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	20.39	0.66	1.55	0.89	0.44	0.00	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	25.86	1.83	1.52	0.91	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	31.86	3.95	1.41	1.13	0.56	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	13.67	1.78	1.19	0.59	1.19	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	14.06	1.56	1.56	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	8.37	0.85	0.85	0.28	0.14	0.00	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	28.01	3.60	1.20	0.80	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	7.34	1.05	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	37.90	2.73	1.86	0.75	0.50	0.00	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.16	1.30	1.09	1.09	0.22	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	14.29	1.71	1.83	0.49	0.12	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	7.96	1.14	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.89	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.68	0.79	0.79	0.31	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	8.25	3.30	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	3.57	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.18	0.49	0.24	0.49	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	8.62	3.28	2.87	1.23	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.93	2.08	1.86	0.66	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.80	2.38	1.19	1.84	0.22	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	16.01	1.58	2.55	0.85	0.49	0.00	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.93	2.05	3.41	0.27	0.14	0.00	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.25	1.79	1.90	0.74	0.53	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	36.10	2.37	3.43	1.05	0.53	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	14.62	2.33	0.66	1.99	0.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	14.97	1.81	1.81	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	8.34	0.76	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.57	2.21	0.95	0.16	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	21.82	1.52	1.82	3.03	0.61	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	26.40	1.78	0.76	1.14	0.13	0.00	0.51
Fibroblast - Cardiac, donor6	11460-119B2	17.13	2.12	1.36	0.45	0.30	0.00	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.74	0.94	0.67	1.07	0.00	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	10.79	1.73	0.86	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	32.23	1.46	2.93	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	3.00	0.00	0.23	0.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	58.85	3.90	2.71	2.37	0.68	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	20.66	2.35	0.70	0.47	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	8.02	1.89	1.42	0.94	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	16.20	3.51	2.30	1.09	0.36	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	21.70	2.26	1.70	0.34	0.00	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	15.35	4.01	1.92	0.87	0.00	0.00	0.52
Fibroblast - Dermal, donor6	11458-119A9	20.63	2.60	1.30	0.65	0.32	0.00	0.49
Fibroblast - Gingival, donor1	11237-116D4	23.32	2.92	3.33	0.83	0.21	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	17.55	2.88	2.10	1.05	0.26	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	20.03	1.71	2.64	1.45	0.40	0.00	0.40
Fibroblast - Gingival, donor3	11394-118C8	27.17	4.83	2.80	2.13	0.00	0.00	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	2.08	2.08	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.75	1.23	1.59	0.88	0.00	0.00	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	13.56	2.49	1.71	1.25	0.16	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.53	1.62	1.62	1.08	0.00	0.14	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.59	1.41	1.76	1.06	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.77	1.46	2.34	0.73	0.15	0.00	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	17.18	1.64	2.05	1.50	0.27	0.00	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.69	1.97	1.43	0.99	0.33	0.00	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	26.27	3.08	2.35	1.17	0.00	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	4.08	0.00	2.72	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	16.41	0.00	4.48	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	10.76	0.42	1.06	0.63	0.00	0.00	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	2.50	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	1.40	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	0.56	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	7.71	0.00	0.00	0.41	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.59	3.49	2.13	1.36	0.39	0.00	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	22.45	2.73	2.43	1.52	0.15	0.00	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	24.48	2.75	2.14	1.22	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.16	1.91	0.76	0.76	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	16.74	1.89	1.62	0.54	0.00	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.02	2.44	1.62	1.39	0.00	0.00	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	21.55	1.66	1.44	0.77	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.52	0.61	0.61	0.41	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	3.34	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	23.72	2.77	1.58	1.58	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	43.86	2.38	2.38	0.20	0.60	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.23	3.37	1.78	1.07	0.18	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.53	4.34	2.76	2.17	0.39	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.30	1.81	3.91	1.20	0.00	0.00	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	35.52	3.35	2.27	1.08	0.32	0.00	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	27.59	1.27	3.04	0.51	0.00	0.00	0.76
Fibroblast - skin normal, donor1	11553-120C5	24.45	5.09	2.30	2.46	0.16	0.00	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	43.71	2.01	5.61	2.21	0.40	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	27.73	4.92	1.61	1.61	0.20	0.00	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	26.29	2.72	3.63	0.91	0.60	0.00	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	32.14	4.56	2.57	1.16	0.25	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	96.07	2.56	2.05	1.03	0.85	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	43.02	1.97	2.30	1.31	0.33	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	38.67	2.66	2.66	1.17	0.21	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	19.23	3.54	2.53	1.18	0.00	0.00	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	29.64	5.96	2.82	3.45	0.63	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	7.84	3.49	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.74	3.29	2.95	1.04	0.17	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	40.34	1.56	2.60	3.12	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	21.72	1.79	1.02	0.51	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	18.37	1.53	1.53	0.77	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	25.52	0.00	0.00	0.00	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	41.93	1.71	0.29	0.57	3.42	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	60.39	1.65	2.21	0.00	1.93	0.00	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.68	1.83	1.60	1.14	1.14	0.00	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	31.90	1.59	1.39	1.39	3.37	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	55.77	2.11	2.38	1.32	0.00	0.00	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	18.26	0.65	1.96	0.00	1.63	0.00	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	35.38	1.33	0.00	0.44	5.31	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	36.60	0.71	0.71	0.14	0.57	0.00	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	33.25	1.48	1.35	0.86	0.86	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.52	1.07	1.07	1.34	0.54	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	28.50	1.12	0.37	0.50	0.37	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	25.89	1.11	0.55	0.42	0.14	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	22.36	0.41	0.41	0.41	1.22	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	33.54	0.68	1.83	0.68	0.46	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	29.52	1.62	1.62	0.62	0.37	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	26.67	0.00	1.09	1.09	0.87	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	42.55	1.77	0.30	1.18	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	36.72	1.43	1.27	0.79	0.32	0.00	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	37.76	2.23	1.12	0.67	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	34.28	1.41	2.02	0.81	0.00	0.00	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.04	1.02	1.02	1.36	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	43.18	1.60	1.24	1.42	0.27	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.49	2.50	1.98	1.04	0.52	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.09	1.71	2.22	0.68	0.00	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	36.18	1.66	1.77	0.89	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.59	2.25	1.50	1.16	0.08	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.96	2.45	1.23	0.82	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	44.56	2.89	2.89	1.65	0.41	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	40.81	3.00	1.50	0.46	0.12	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	36.02	1.17	2.17	0.17	0.33	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	41.44	1.54	2.20	2.65	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	56.21	3.07	2.09	1.48	0.00	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.01	1.62	1.95	0.49	0.16	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	65.75	3.21	2.25	0.64	0.64	0.00	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	32.22	1.80	2.56	1.33	0.00	0.00	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	33.85	2.21	1.74	0.47	0.16	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	44.40	0.91	1.22	0.61	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.85	2.30	3.03	1.15	0.00	0.00	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	43.25	1.76	1.76	0.88	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.72	3.09	2.52	0.84	0.56	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.61	1.67	1.11	0.74	0.09	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	35.83	0.53	2.14	1.34	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	25.25	0.46	1.38	0.77	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	22.54	0.91	2.20	1.30	0.13	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.63	3.52	2.17	0.54	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	29.50	1.66	1.66	0.74	0.74	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	31.80	2.19	1.54	0.88	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	47.60	4.96	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.56	1.19	2.24	0.79	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.39	1.41	0.61	1.61	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	50.32	3.81	0.76	1.27	0.51	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	44.39	1.00	0.40	0.00	0.40	0.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.98	0.77	1.39	0.15	0.00	0.00	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	30.28	1.23	0.82	0.00	1.02	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	30.04	0.00	0.63	0.31	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	21.19	1.41	0.28	0.57	1.41	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	19.37	0.92	0.92	0.46	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	32.17	0.00	0.00	0.00	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.52	1.16	0.00	0.39	1.93	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	60.97	0.00	1.60	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	1.74	3.48	0.00	1.74	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	41.99	1.63	0.98	0.33	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	44.47	1.24	0.82	0.00	2.47	0.00	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	0.00	0.00	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	50.34	1.12	0.84	0.56	0.56	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	46.74	1.63	0.98	0.65	0.65	0.00	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	32.71	0.84	1.68	0.00	0.00	0.00	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	54.07	1.59	1.91	0.32	0.64	0.00	3.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	51.97	1.36	1.02	0.34	0.68	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	83.53	2.09	0.00	0.00	0.00	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	65.29	2.29	0.57	0.00	2.29	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	40.55	0.59	0.59	0.00	0.89	0.00	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	0.00	0.00	0.00	0.00	0.00	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	49.29	0.41	0.00	0.83	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	50.17	1.15	0.46	0.46	0.69	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	0.00	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	43.44	0.77	0.00	0.77	0.77	0.00	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	38.79	0.98	2.61	1.30	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	61.53	4.68	3.34	0.67	0.67	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	87.46	3.47	1.93	0.39	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	58.54	2.05	2.05	1.03	1.03	0.00	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	64.60	0.00	2.48	0.00	2.48	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	83.05	4.72	2.83	0.94	1.89	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	65.78	3.02	0.60	0.60	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	76.30	3.05	2.54	0.51	0.51	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	85.75	1.60	1.20	1.20	1.20	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	79.43	4.44	0.99	2.47	1.48	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	90.89	2.36	1.18	0.00	2.36	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	75.26	2.33	0.58	1.17	1.17	0.00	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	96.55	4.83	1.76	0.44	0.44	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	58.49	0.85	1.70	0.85	1.70	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.86	0.60	1.19	0.60	0.60	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	43.19	1.46	2.43	0.49	0.49	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	2.28	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.07	1.66	0.83	1.25	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	1.12	2.25	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	37.74	2.22	1.59	2.54	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.06	5.01	1.25	2.51	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.88	2.90	2.32	1.51	0.35	0.00	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.47	4.22	2.36	1.35	0.17	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	9.10	2.05	1.37	1.14	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.46	2.62	1.75	1.31	0.44	0.00	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.25	3.01	1.72	0.86	0.43	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.55	2.58	1.72	2.80	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.58	2.12	2.12	1.49	0.87	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.92	3.43	1.03	1.20	0.69	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.57	3.84	1.28	1.60	0.64	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	2.24	0.56	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	0.00	0.00	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	0.00	2.64	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.29	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.91	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	12.59	0.52	0.35	0.70	0.00	0.00	0.17
Hepatocyte, donor1	11523-119I2	8.47	0.00	0.00	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	22.62	1.08	0.00	5.39	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	5.52	2.45	1.23	1.84	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	37.86	2.61	3.26	1.31	3.26	0.00	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.27	0.87	1.05	0.35	0.17	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	21.13	1.65	1.92	0.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	2.50	2.50	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	0.00	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	1.62	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	0.00	5.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	22.50	0.00	5.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	13.30	3.33	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	28.97	1.89	4.41	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	0.00	1.55	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	1.94	1.29	1.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	1.61	3.22	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	37.48	2.44	1.63	1.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	21.41	0.84	1.26	1.68	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	24.91	2.41	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	0.00	0.92	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	26.43	1.89	1.89	1.89	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	30.84	0.00	0.91	0.91	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	31.21	3.23	4.30	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	34.30	0.00	1.27	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	34.43	1.28	1.91	1.91	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	0.00	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	26.42	1.43	6.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	27.16	1.85	1.54	0.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	1.76	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	34.07	1.39	2.09	1.39	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	8.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	0.00	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	1.74	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	2.25	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	3.20	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	18.41	0.92	3.68	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	0.00	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	28.55	0.00	0.00	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	18.03	0.82	1.31	0.90	0.33	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	8.78	1.17	0.59	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	18.08	3.22	2.56	1.70	0.19	0.00	0.09
Keratinocyte - oral, donor1	11251-116E9	77.76	4.65	5.34	2.27	0.00	0.00	0.34
Keratocytes, donor1	11527-119I6	5.50	0.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	3.52	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	23.71	1.98	1.58	0.40	0.20	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	0.00	2.20	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	12.94	1.08	1.08	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	41.06	2.08	1.61	1.04	0.35	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	15.44	0.91	0.50	0.10	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	27.27	1.90	2.13	1.07	0.12	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.63	1.40	1.40	0.28	0.56	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	17.16	0.94	1.57	0.47	0.47	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	19.36	0.00	1.08	0.54	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.50	0.95	1.58	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.48	0.65	0.75	0.75	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	21.34	1.23	1.64	0.82	0.00	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	10.87	1.01	0.51	0.76	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.81	1.41	0.70	0.56	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.87	1.58	0.40	0.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	17.84	1.55	0.39	0.97	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.41	0.37	0.37	0.00	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.18	1.39	0.70	0.35	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	17.17	0.95	1.19	0.00	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.61	0.96	0.41	0.41	0.69	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.56	0.92	0.92	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.29	0.62	0.94	1.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.71	0.55	0.55	0.00	0.00	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.82	1.97	0.33	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.89	0.59	0.29	0.88	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.21	0.25	0.25	0.00	0.50	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.88	1.94	0.97	0.00	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.97	1.62	1.35	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.05	0.61	1.21	0.15	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	17.11	2.07	0.52	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	18.64	1.47	1.68	0.63	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.42	0.90	1.35	0.45	0.30	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	1.38	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.37	1.13	0.94	0.00	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.69	1.17	0.95	0.53	0.32	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	0.97	0.48	0.00	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.23	0.66	0.66	0.66	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.29	1.12	0.50	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.62	0.74	0.74	1.11	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.31	0.74	1.73	0.25	1.24	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	13.34	0.27	0.82	0.82	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.12	0.32	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.56	0.91	0.91	0.00	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.84	1.12	0.42	0.70	0.14	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	24.53	1.07	0.36	0.00	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.18	0.48	0.00	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.22	0.93	0.78	0.16	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.68	3.58	1.79	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.51	1.31	0.98	0.65	0.33	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.18	0.94	0.24	0.47	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.40	0.87	1.49	0.37	0.12	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.73	0.77	0.77	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.65	1.19	0.60	0.00	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	6.80	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	4.60	1.53	0.77	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.94	1.48	2.23	0.00	2.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.16	1.27	1.27	0.85	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	2.11	0.70	0.70	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	1.87	0.00	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.73	2.06	0.52	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	2.38	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.50	1.13	1.36	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	9.89	1.16	1.16	0.87	0.29	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.35	0.90	0.90	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	12.06	1.08	0.95	1.22	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	1.54	1.03	0.00	1.03	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	7.76	1.41	0.35	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3.33	1.33	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	6.62	2.04	0.51	1.02	1.02	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	8.54	2.13	0.80	1.33	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	10.39	1.13	0.19	0.94	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.98	1.84	0.61	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	10.60	1.63	1.63	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.45	1.25	1.46	0.83	0.42	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	9.53	2.24	0.28	1.12	1.96	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	0.00	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.90	1.45	2.90	0.58	0.58	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.76	2.09	0.90	0.60	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.85	2.77	2.21	0.55	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	8.48	1.77	1.06	1.06	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	3.69	2.21	0.74	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	0.00	1.15	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.59	2.30	0.00	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.76	0.57	1.70	1.13	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	12.31	0.82	2.46	3.28	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.78	0.90	0.00	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	8.62	2.15	0.72	1.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	2.99	2.24	1.49	2.24	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.52	3.72	2.23	1.11	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	7.75	1.29	0.86	0.86	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.99	0.86	0.86	1.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.33	1.00	0.67	0.33	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.83	0.60	1.81	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	2.84	2.13	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	7.91	0.69	1.72	1.03	0.34	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	11.81	1.61	2.68	0.54	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.06	1.35	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	10.74	1.85	0.74	2.59	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	1.16	1.16	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	0.00	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.00	0.40	1.20	1.60	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.81	0.73	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14.56	1.53	0.77	1.53	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.88	0.99	1.97	0.49	1.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	1.88	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.55	4.02	2.01	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.21	1.80	0.45	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	0.00	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	9.80	0.89	0.45	0.89	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.60	1.56	1.96	0.78	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.94	0.66	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6.23	2.08	1.04	0.52	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	8.31	1.31	1.31	0.44	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.27	1.68	0.56	1.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.04	2.65	1.32	0.88	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.96	1.16	0.77	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.58	0.51	0.00	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	8.17	0.48	0.00	0.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	8.75	1.99	0.40	1.19	0.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.94	2.43	1.22	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.92	1.38	0.00	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	7.60	1.52	2.28	0.38	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	12.39	1.55	1.03	1.03	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	2.42	1.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.77	0.63	1.27	0.63	0.95	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.26	2.13	1.07	2.13	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.07	1.72	0.57	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	4.63	2.06	0.51	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	5.66	2.83	1.41	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	3.40	0.57	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	6.66	4.16	2.08	0.83	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	6.26	0.00	0.78	0.78	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.44	2.09	0.42	0.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	8.83	0.93	1.39	0.46	1.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.04	2.01	0.00	0.00	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.95	1.60	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	4.04	1.62	0.40	1.62	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	1.84	0.92	0.00	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	0.89	0.89	0.89	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.12	1.14	1.14	2.85	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	1.53	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.21	2.19	0.00	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.46	0.89	0.89	0.00	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.32	0.78	1.30	0.52	0.78	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.95	1.99	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	2.08	2.08	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	126.72	6.84	7.98	3.19	1.14	0.00	1.37
Macrophage - monocyte derived, donor2	11313-117C8	53.77	6.06	6.06	2.02	1.10	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	67.11	4.85	5.90	2.88	0.66	0.00	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	36.11	2.12	2.12	2.12	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	57.68	2.85	3.01	1.43	0.00	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	50.04	2.78	2.08	0.83	0.28	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	29.49	3.29	3.29	1.30	1.30	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	30.11	2.03	3.19	0.87	0.29	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	5.49	0.75	0.75	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	17.63	4.75	4.07	3.39	0.00	0.00	0.68
Mast cell, donor1	11563-120D6	16.44	5.73	3.57	4.43	0.11	0.00	1.08
Mast cell, donor2	11565-120D8	19.61	3.86	3.57	3.57	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	24.99	3.60	4.05	3.83	0.00	0.00	0.23
Mast cell, donor4	11567-120E1	14.71	3.19	2.13	6.21	0.35	0.00	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	15.64	3.11	3.66	4.55	0.00	0.00	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	12.26	2.33	1.17	2.33	0.00	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	19.50	4.02	3.33	2.52	0.00	0.00	0.57
Mast cell, expanded, donor8	11941-126A6	16.74	4.85	3.68	5.19	0.33	0.00	1.34
Melanocyte - dark, donor1	11502-119F8	33.13	1.59	1.89	1.09	0.50	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	17.30	1.04	1.73	0.35	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	36.66	3.19	4.56	3.11	0.00	0.00	0.29
Melanocyte - light, donor1	11274-116H5	10.58	1.41	2.12	2.59	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	8.19	0.00	0.68	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.07	1.73	1.73	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	36.55	3.75	2.92	2.29	0.10	0.00	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	40.34	0.81	2.69	2.42	0.00	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	34.82	3.21	4.02	3.75	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	13.27	1.12	1.24	0.12	0.12	0.00	0.25
Meningeal Cells, donor2	11573-120E7	11.88	0.88	0.88	0.44	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	20.86	1.06	1.47	1.06	0.16	0.00	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	24.52	0.57	1.71	0.29	0.29	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.39	1.81	1.51	1.31	0.10	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	16.50	1.44	2.87	0.72	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.76	1.69	2.96	0.42	0.00	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.55	1.01	0.00	1.51	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.40	0.66	0.44	0.00	0.00	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	0.73	1.46	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.71	0.82	0.61	0.61	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	41.00	4.02	1.39	1.25	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	0.00	0.37	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	59.73	3.03	3.16	1.58	0.39	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.12	0.59	0.89	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	32.96	3.19	4.25	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	42.84	3.75	3.75	2.50	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	19.59	2.18	3.63	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	36.33	1.86	3.18	1.06	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	30.03	2.50	3.50	2.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	19.95	2.38	2.31	1.16	0.00	0.00	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	0.00	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	65.51	5.42	3.45	1.23	1.48	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	39.46	5.30	3.83	2.65	1.18	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	67.26	5.27	3.41	0.62	1.24	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	46.05	3.11	6.43	2.49	1.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	72.33	5.51	4.00	1.75	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	36.77	4.19	2.79	0.93	0.93	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	83.93	4.06	4.88	1.83	0.81	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	36.82	2.77	3.17	3.17	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	17.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	80.53	3.54	0.88	3.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	59.65	4.94	5.70	3.04	1.90	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	74.70	4.67	2.76	1.27	0.64	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	0.00	2.76	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	41.73	2.09	1.79	1.79	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	75.27	5.02	2.26	2.01	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.95	4.75	4.28	2.38	0.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	0.55	0.55	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	60.32	5.07	2.99	2.53	0.46	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	38.70	4.84	4.84	2.10	0.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	45.25	3.87	2.65	1.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	74.87	2.79	2.79	2.15	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.45	4.00	2.45	2.22	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	38.77	2.41	1.31	1.53	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	2.03	3.04	2.53	0.51	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	34.25	1.63	0.82	0.00	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	24.41	2.06	2.06	2.06	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	44.21	2.40	0.48	1.44	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	28.02	5.60	2.40	0.80	1.20	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	0.00	1.37	2.74	0.00	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	29.53	2.50	1.50	1.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	31.09	1.31	1.75	0.44	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	0.00	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	6.40	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	30.74	2.73	0.74	0.99	0.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	1.39	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	2.21	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	38.97	1.37	3.08	1.03	1.03	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.88	1.75	0.44	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.39	0.71	0.71	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	39.28	3.37	1.68	1.40	0.84	0.00	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.98	2.08	1.66	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	1.17	0.00	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.62	1.81	2.11	1.81	0.90	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	32.97	2.50	5.84	1.67	1.67	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	3.69	0.92	1.85	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	28.46	2.85	4.55	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.51	2.21	2.35	0.28	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	45.35	2.59	2.33	1.30	1.81	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	30.89	3.00	2.14	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	1.27	1.27	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	18.95	2.14	2.14	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	50.29	5.69	3.59	1.20	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	18.22	2.68	1.55	0.85	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	43.32	3.50	3.19	1.59	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	31.84	4.20	3.98	1.33	0.88	0.00	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.00	1.90	0.76	1.52	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	48.01	3.13	3.69	0.85	1.42	0.00	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	46.70	5.16	5.65	0.98	1.72	0.00	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	2.61	0.65	0.65	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	32.64	2.94	2.94	1.76	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	48.15	6.92	6.92	1.44	1.73	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	71.71	2.47	4.53	2.06	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	37.82	3.57	2.08	1.19	0.00	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	75.34	7.53	7.53	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	114.06	8.91	5.35	5.35	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	73.93	6.90	5.26	2.96	0.99	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	70.48	7.36	2.10	1.05	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	101.81	7.31	4.15	5.73	1.19	0.00	1.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	89.41	15.83	6.52	3.73	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	84.87	9.76	4.88	3.76	1.88	0.38	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	50.61	7.46	4.79	2.93	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	76.91	4.18	3.28	2.94	0.23	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	69.25	5.89	5.16	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	53.13	8.06	2.93	2.56	1.10	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	60.67	4.67	0.00	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	104.22	8.02	8.55	5.88	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	0.00	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	50.50	10.10	3.03	2.02	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	51.86	8.01	5.48	5.06	1.69	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	81.72	5.45	8.17	5.45	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	178.02	10.81	8.90	5.09	2.54	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	136.86	14.58	12.15	6.48	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	72.50	6.04	1.51	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	91.35	13.05	13.05	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.87	0.86	1.94	1.08	0.22	0.00	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	14.11	3.14	2.61	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	7.34	0.00	0.00	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.34	1.25	0.42	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.69	3.99	3.04	1.52	0.00	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	4.79	3.19	0.00	6.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	2.72	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	29.40	1.84	1.84	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.53	1.26	1.67	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	10.69	2.09	2.09	1.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.84	1.89	0.81	1.08	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	7.15	1.05	0.84	1.47	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00	0.00	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.95	1.49	0.50	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.78	4.06	1.08	0.81	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.01	0.91	0.45	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.14	2.12	1.96	0.49	0.16	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.04	1.46	1.28	0.55	0.36	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.55	1.06	1.06	2.12	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	1.20	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	38.72	2.95	4.27	0.98	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.08	1.79	0.98	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.11	0.53	1.06	0.35	0.71	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	1.41	3.52	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.17	2.30	1.84	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.89	0.64	0.64	1.29	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	47.59	3.79	2.41	2.07	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	2.53	7.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.47	2.23	1.34	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.89	5.08	4.23	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.23	3.09	1.66	1.66	0.24	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	14.59	3.43	1.72	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	9.03	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.33	3.00	2.00	2.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	5.86	1.80	1.35	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.97	2.38	1.19	0.40	0.79	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	8.36	1.86	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.84	1.89	1.89	1.89	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.75	2.28	0.98	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.15	4.36	3.92	1.74	1.74	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	2.26	1.81	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	3.53	2.65	2.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	1.33	1.33	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.93	2.98	1.49	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.95	1.15	1.15	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.96	4.54	3.63	3.02	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.27	1.77	1.33	0.44	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	0.68	3.39	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	0.00	5.11	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	5.49	1.83	1.22	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	8.81	3.78	0.31	1.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.71	4.84	3.63	2.12	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.20	1.58	1.58	1.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	24.94	7.94	1.13	5.67	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	10.12	0.00	5.06	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	13.79	2.61	1.74	1.49	0.12	0.00	0.50
Myoblast, donor2	11322-117D8	14.96	2.49	1.53	0.77	0.00	0.00	0.00
Myoblast, donor3	11398-118D3	14.29	2.19	3.53	1.01	0.17	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	34.88	6.57	3.21	2.33	0.29	0.00	1.17
Natural Killer Cells, donor1	11230-116C6	23.37	3.69	0.62	3.69	1.85	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	15.98	8.75	2.11	5.43	0.90	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	16.01	6.07	2.39	6.99	0.92	0.00	0.74
Neural stem cells, donor1	11275-116H6	34.48	1.81	0.73	0.00	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	38.51	3.85	0.00	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	20.48	1.14	2.28	3.41	0.00	0.00	0.00
Neurons, donor2	11574-120E8	25.10	2.64	3.08	0.22	0.00	0.00	0.22
Neurons, donor3	11655-122E8	15.62	1.64	2.47	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	8.35	12.06	1.86	1.86	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	9.16	9.16	3.05	4.28	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	50.70	3.68	3.44	1.07	0.24	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	31.26	0.65	0.65	0.65	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	17.85	2.61	0.60	0.60	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	20.23	2.89	1.93	1.51	0.28	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	39.37	2.17	2.46	1.30	0.72	0.00	0.43
Olfactory epithelial cells, donor3	11935-125I9	27.92	4.54	2.50	1.70	1.02	0.00	0.23
Olfactory epithelial cells, donor4	11936-126A1	36.43	3.90	3.90	2.53	0.58	0.00	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	40.32	1.20	1.81	0.60	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	14.68	2.34	3.19	2.34	0.21	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	14.86	0.00	1.14	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.76	4.34	0.62	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	7.43	0.39	0.20	0.39	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	9.83	1.40	0.70	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	10.49	1.60	1.07	0.71	0.53	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	33.86	2.11	2.27	1.10	0.17	0.00	0.76
Pericytes, donor1	11491-119E6	4.01	0.11	0.22	0.00	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	3.40	0.45	0.68	0.23	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	5.90	1.42	0.61	0.41	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	30.06	2.37	2.83	1.47	0.11	0.00	0.11
Perineurial Cells, donor2	11579-120F4	27.24	2.39	1.29	0.92	1.10	0.00	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	67.25	10.84	5.74	5.42	0.32	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	32.08	5.63	2.69	3.92	0.49	0.00	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	35.85	6.34	3.62	4.66	0.52	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	8.61	0.48	1.43	0.72	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	23.29	1.11	1.11	2.22	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.37	0.98	1.18	0.98	0.59	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.61	2.22	1.58	3.16	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	22.70	0.56	2.06	1.50	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.84	1.31	3.39	1.04	0.78	0.00	1.31
Preadipocyte - breast, donor2	11328-117E5	18.91	2.70	2.93	2.25	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	30.16	2.13	2.77	2.45	0.43	0.00	0.43
Preadipocyte - omental, donor2	11329-117E6	24.44	3.49	5.24	1.75	0.87	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	20.48	3.29	3.58	1.58	0.00	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	18.70	3.94	2.95	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	7.06	0.61	0.31	0.00	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	17.35	2.12	2.66	0.89	0.18	0.00	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	15.16	1.02	2.04	0.68	0.00	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	23.66	1.02	1.68	0.93	0.09	0.00	0.28
Preadipocyte - visceral, donor2	11357-117H7	19.79	1.38	0.92	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	13.37	1.78	1.88	0.10	0.10	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.47	0.30	0.15	0.15	0.15	0.00	0.60
Prostate Epithelial Cells, donor2	11331-117E8	24.78	0.27	0.68	0.14	0.00	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	20.64	5.08	3.74	1.47	0.12	0.00	0.12
Prostate Stromal Cells, donor1	11254-116F3	15.72	1.14	1.03	0.46	0.23	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	14.70	1.43	1.08	0.72	0.18	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	17.52	2.82	2.82	1.56	0.21	0.00	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.93	1.09	0.36	1.09	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	47.55	1.94	2.43	1.87	0.21	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	2.54	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.27	0.00	0.00	2.13	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	50.82	1.38	1.59	2.01	1.16	0.00	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.66	1.08	0.13	0.13	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	14.65	1.33	0.67	0.89	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.67	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.52	0.44	0.22	0.00	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.64	0.63	0.63	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.55	0.00	0.55	0.00	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	17.18	1.61	2.15	0.54	0.54	0.00	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	7.17	0.42	1.27	1.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	3.28	0.77	0.58	0.77	0.19	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	32.15	2.59	2.59	1.30	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.52	0.85	0.85	0.85	1.14	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	1.03	0.00	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	47.67	1.25	1.51	1.25	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	56.13	4.14	2.54	2.94	1.47	0.00	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	50.92	3.57	5.36	1.79	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	101.27	3.30	4.40	1.10	0.00	0.00	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	50.46	3.48	1.74	1.16	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	36.80	2.21	2.08	0.00	0.00	0.00	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	25.72	2.58	1.69	0.50	0.00	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	44.39	3.57	3.90	1.23	0.00	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	57.68	2.73	3.23	0.87	0.00	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	34.03	1.98	3.85	1.28	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	51.08	2.31	2.54	1.62	0.00	0.00	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	29.02	1.51	2.19	0.96	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	32.37	1.97	3.03	0.76	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	36.55	1.97	2.87	1.25	0.00	0.00	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	38.02	2.01	2.73	0.72	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	32.84	2.90	2.04	1.29	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	35.40	2.88	2.43	1.99	0.00	0.00	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	27.15	1.91	1.15	0.76	0.00	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	26.18	2.52	1.96	0.37	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	55.81	2.63	4.32	1.13	0.00	0.00	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	25.75	0.80	1.46	0.66	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	28.81	1.85	2.34	1.07	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	39.72	2.29	2.86	1.15	0.00	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.76	2.24	1.82	0.43	0.00	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	27.75	1.68	3.36	1.12	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	27.17	1.37	2.56	0.68	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	25.89	2.55	1.64	1.28	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.35	2.94	2.70	0.98	0.00	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	35.86	3.36	2.55	1.34	0.00	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	41.28	2.83	2.12	0.47	0.00	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	33.14	2.98	3.97	0.40	0.00	0.00	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	39.05	2.34	4.21	0.94	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	38.78	2.70	1.87	0.41	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	37.16	2.43	1.77	0.44	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.57	1.25	2.30	0.84	0.00	0.00	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	30.82	3.50	2.42	0.67	0.00	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	18.39	2.04	1.19	0.51	0.17	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	33.93	2.51	2.12	0.77	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	45.05	2.41	1.72	0.86	0.00	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.11	1.78	1.51	0.82	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	32.18	2.30	1.97	1.15	0.00	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	35.11	2.90	1.19	0.51	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	32.70	3.55	3.11	0.89	0.00	0.00	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.45	0.27	1.87	0.53	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	44.38	1.80	1.80	0.14	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	42.86	2.62	2.14	0.71	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.92	2.02	2.82	1.41	0.00	0.00	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	54.90	2.35	2.54	0.75	0.00	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	65.33	1.40	3.49	0.70	0.00	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	38.99	1.21	0.60	0.60	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	54.58	2.94	1.47	0.86	0.12	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	90.82	3.35	4.22	1.75	0.00	0.00	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	73.62	6.08	2.43	0.61	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.46	2.41	3.92	1.21	0.00	0.00	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	63.56	2.26	2.94	2.04	0.00	0.00	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	60.21	4.19	5.39	1.50	0.00	0.00	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	87.97	3.07	2.95	1.42	0.00	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	49.31	2.35	2.99	2.13	0.00	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	57.69	3.00	1.80	0.60	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	2.07	0.56	0.38	0.19	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	14.24	1.53	1.53	1.10	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	15.34	0.55	1.10	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	12.41	1.38	2.76	1.38	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	10.72	2.89	2.27	1.44	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	56.32	3.31	1.66	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	48.01	0.00	0.00	0.00	5.65	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	22.26	0.18	0.70	0.44	0.26	0.00	0.35
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.00	0.72	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	0.84	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	16.65	1.73	1.73	0.94	0.00	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	19.77	1.93	1.49	0.89	0.15	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	18.01	3.54	2.15	1.39	0.00	0.00	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	33.27	3.53	1.89	3.02	0.63	0.00	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	23.26	3.14	1.57	1.43	0.14	0.00	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.45	2.68	1.88	1.39	0.00	0.00	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	14.49	0.51	0.84	0.00	0.25	0.00	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.79	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.64	0.28	0.69	0.28	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	2.69	5.37	0.00	13.43	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.32	1.87	1.30	0.72	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	58.07	4.09	4.91	0.00	0.00	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.93	1.04	1.17	0.91	1.04	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	41.84	2.22	3.20	1.81	0.42	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	17.72	0.98	1.27	0.56	0.14	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	59.63	1.27	3.59	0.63	1.48	0.00	2.54
Small Airway Epithelial Cells, donor3	11406-118E2	18.14	3.00	1.80	1.05	0.22	0.00	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	18.52	4.32	1.54	1.23	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	39.80	1.78	5.11	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	10.58	0.59	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.52	0.88	1.10	0.22	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.09	0.39	0.79	0.39	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	0.77	0.00	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	56.04	1.00	1.00	1.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.32	0.67	1.46	0.27	0.27	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	20.39	3.10	3.10	1.11	0.00	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.24	3.07	1.41	0.77	0.26	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	22.14	0.33	0.33	0.33	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.36	0.89	0.59	1.48	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	21.21	1.42	2.42	0.43	0.28	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.60	0.33	0.33	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.83	1.52	0.91	1.52	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.33	1.52	0.51	0.51	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	0.00	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.95	1.03	1.77	0.29	0.44	0.00	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.70	0.65	1.94	0.43	0.00	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.34	1.89	1.78	1.47	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.95	0.46	0.93	0.62	0.31	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	1.08	2.16	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.17	0.90	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	1.02	0.34	0.34	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	64.00	3.77	3.53	1.49	0.16	0.00	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	14.09	1.51	0.81	0.50	0.10	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	13.65	1.37	1.59	1.14	0.46	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	14.49	3.02	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	27.29	1.06	1.06	1.06	0.53	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.50	2.80	1.73	0.53	0.00	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.91	1.38	1.25	0.88	0.25	0.00	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	36.27	3.55	3.04	1.52	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	13.57	1.06	1.66	0.30	0.45	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.00	1.50	2.25	1.50	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3.88	1.29	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.23	3.26	1.86	1.40	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.19	0.50	0.50	0.50	0.00	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.40	1.88	1.25	0.94	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.31	2.06	1.77	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.99	2.08	1.17	1.67	0.00	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	22.89	0.47	1.40	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	7.48	1.01	0.58	0.58	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	9.18	1.53	1.02	0.51	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.89	1.13	0.38	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.43	2.79	1.68	1.40	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	31.09	1.93	2.93	1.42	0.08	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	0.00	0.95	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.07	0.73	0.73	0.73	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.77	2.65	1.77	0.66	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.01	1.17	2.34	0.88	0.29	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	32.46	4.28	2.53	1.75	0.39	0.00	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.60	3.44	2.12	1.59	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	61.74	5.21	2.23	1.12	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	26.95	2.87	1.80	2.16	0.00	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	14.76	2.27	2.27	0.57	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.06	1.58	1.58	0.39	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	44.44	3.05	1.02	0.51	0.00	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	37.14	4.79	3.19	0.40	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	33.44	3.34	1.25	0.84	0.00	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	24.75	3.21	2.29	0.46	0.92	0.00	0.46
Synoviocyte, donor1	11291-117A4	20.87	1.18	1.01	1.01	0.00	0.00	0.00
Synoviocyte, donor2	11368-117I9	18.61	3.02	1.51	1.51	0.50	0.00	0.00
Synoviocyte, donor3	11440-118H9	28.37	5.59	1.56	1.56	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	5.00	0.71	0.36	1.07	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.33	0.23	0.46	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	22.72	1.36	1.22	0.22	0.00	0.00	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	11.98	0.77	1.16	0.39	0.00	0.00	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	5.73	1.15	0.00	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	55.73	4.06	3.44	2.71	1.23	0.00	0.62
Urethra, donor2	10319-105A4	10.79	7.19	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2.66	0.53	0.27	0.27	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	5.21	1.60	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	5.96	0.92	0.92	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	55.28	7.36	6.69	1.56	1.11	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	56.06	15.13	4.45	3.56	0.00	1.78	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	68.62	18.58	2.86	2.86	0.00	0.00	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.17	5.48	6.16	3.42	0.00	0.00	3.42
Whole blood (ribopure), donor090325, donation1	12176-128I7	50.96	6.20	3.44	2.75	3.10	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	71.47	13.36	2.91	5.23	2.91	0.00	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	59.35	15.62	0.00	6.25	0.00	0.00	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	69.75	24.78	3.67	0.00	0.00	0.92	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	35.60	14.61	4.56	10.04	0.00	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	21.96	1.60	0.99	0.74	0.25	0.00	0.25
Wilms' tumor cell line:HFWT	10597-108E3	8.80	1.76	0.88	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.36	1.40	0.56	0.28	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	24.80	0.00	2.07	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	40.03	2.04	2.80	0.51	8.41	15.04	2.55
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	42.49	0.93	3.02	1.39	1.16	0.00	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	54.13	2.85	2.73	0.71	2.37	0.00	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	37.01	3.27	1.90	0.82	4.63	0.00	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	27.83	1.97	1.69	1.69	0.00	0.00	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	45.47	2.75	3.60	2.33	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	45.73	5.17	1.63	3.27	0.54	0.00	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.93	1.32	1.32	0.88	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	30.22	2.45	2.04	3.27	0.41	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.09	2.72	3.11	1.94	0.78	0.39	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	28.34	3.13	2.94	1.10	0.00	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	7.80	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	32.30	1.16	3.72	1.16	1.16	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	58.51	4.92	5.95	2.59	0.52	0.00	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	29.81	2.05	2.92	0.88	0.29	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	24.63	4.18	1.39	2.79	0.00	0.00	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	35.37	1.65	2.88	0.82	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	9.52	8.29	3.68	2.15	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	52.06	6.40	11.09	2.13	0.43	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	61.87	9.40	9.10	3.34	0.30	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	74.62	5.78	6.26	3.61	0.00	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	13.59	2.23	1.78	1.11	0.00	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	15.01	1.00	1.00	2.33	0.33	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	1.86	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.73	1.88	2.64	1.51	0.00	0.00	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	40.12	3.49	1.74	3.49	0.87	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	20.62	3.75	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	48.28	10.13	15.07	2.83	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	54.91	6.67	2.33	3.57	0.93	0.00	0.16
adipose, donor1	10184-103D4	125.49	1.17	2.93	1.17	1.76	0.00	1.17
adipose, donor2	10185-103D5	31.63	0.81	1.22	0.41	0.00	0.00	0.81
adipose, donor3	10186-103D6	22.06	1.63	1.36	0.82	1.09	0.00	0.82
adipose, donor4	10187-103D7	34.67	0.87	0.00	0.00	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	12.78	8.05	5.84	2.84	0.16	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	25.46	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	20.41	5.20	4.54	1.60	0.13	0.00	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	28.23	1.79	1.79	0.36	0.00	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	17.16	4.41	4.87	6.49	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	38.21	6.76	2.03	7.44	0.68	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	25.04	8.25	3.83	9.13	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	14.23	1.19	2.37	0.00	0.00	0.00	2.37
amygdala, adult, donor10252	10151-102I7	15.41	1.42	1.82	2.43	0.00	0.00	0.81
amygdala, newborn, donor10223	10360-105E9	12.59	0.97	2.90	0.65	1.29	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	40.36	4.20	1.27	1.02	0.64	0.00	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	13.90	4.41	1.54	3.75	0.22	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	35.74	1.00	1.00	0.67	0.67	0.00	1.34
aorta, adult, pool1	10052-101G7	19.81	4.51	1.96	2.94	0.20	0.00	0.39
appendix, adult	10189-103D9	45.02	3.88	2.33	2.72	11.64	4.27	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	61.22	2.41	1.03	0.69	0.34	0.00	2.06
artery, adult	10190-103E1	14.95	1.36	1.36	4.08	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	58.96	4.93	3.77	2.46	1.16	0.00	0.00
b cell line:RPMI1788	10427-106D4	67.96	4.61	1.93	2.53	11.90	9.52	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	31.91	1.94	3.61	0.83	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	23.62	1.29	2.38	0.99	0.00	0.00	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	25.44	6.86	3.51	1.17	0.33	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	53.69	9.51	6.15	1.68	0.00	0.00	1.12
bladder, adult, pool1	10011-101C2	42.91	3.48	2.17	4.78	0.87	0.11	0.22
blood, adult, pool1	10053-101G8	22.15	11.07	4.43	0.00	0.00	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	0.86	0.00	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	93.13	6.07	5.40	2.70	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	6.15	1.03	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	13.92	2.90	2.00	2.90	0.11	0.00	0.22
brain, fetal, pool1	10085-102B4	10.69	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	11.56	2.97	1.65	4.29	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	40.07	4.87	3.87	6.37	0.62	0.00	0.75
breast, adult, donor1	10080-102A8	33.46	7.58	4.42	2.53	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	14.48	2.79	3.81	1.78	0.38	0.00	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.88	1.86	1.86	1.24	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	21.18	3.45	3.22	1.15	0.00	0.00	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	8.96	2.66	1.21	0.73	0.48	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	34.32	3.29	2.82	0.47	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	26.58	1.53	1.53	0.66	0.00	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	34.22	1.58	5.07	0.32	1.58	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	62.29	1.60	2.93	0.53	0.27	0.00	0.53
caudate nucleus - adult, donor10196	10177-103C6	26.48	6.91	3.45	2.30	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	19.74	3.68	2.51	2.84	0.17	0.17	0.50
caudate nucleus, adult, donor10258	10379-105H1	18.34	5.35	4.58	0.00	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	19.78	2.56	2.93	0.37	1.10	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	69.92	8.74	5.83	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	62.13	6.19	6.83	7.26	1.07	0.00	3.42
cerebellum, adult, pool1	10083-102B2	22.08	4.48	5.86	4.83	0.00	0.00	1.38
cerebellum, newborn, donor10223	10357-105E6	69.74	1.66	3.32	4.15	0.83	0.00	1.66
cerebral meninges, adult	10188-103D8	7.82	2.77	2.02	1.01	0.00	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	16.08	0.00	1.46	2.92	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	58.81	10.64	10.21	11.50	0.86	0.00	1.29
cervical cancer cell line:ME-180	10553-107I4	15.58	0.83	1.16	0.17	0.00	0.00	0.17
cervix, adult, pool1	10013-101C4	28.03	2.41	2.20	2.94	0.52	0.00	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	16.02	2.51	1.53	1.81	0.28	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	1.31	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	57.17	2.36	3.11	1.24	0.87	0.00	0.50
choriocarcinoma cell line:SCH	10785-110H2	54.71	4.81	2.96	1.72	0.12	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	39.13	2.13	1.42	0.24	0.00	0.00	0.71
chorionic membrane cells, donor1	12238-129G6	32.48	1.99	2.56	2.56	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	37.19	2.78	3.58	1.89	0.50	0.00	0.40
chorionic membrane cells, donor3	12240-129G8	58.25	2.20	1.65	0.00	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	20.20	2.02	1.01	2.02	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	26.13	3.07	2.88	1.73	0.77	0.00	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	39.91	4.01	2.53	1.06	0.42	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	38.26	2.31	2.57	1.28	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	36.04	3.87	3.14	1.69	0.00	0.00	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	38.28	1.83	3.46	2.04	0.00	0.00	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	56.83	2.65	4.42	1.18	0.29	0.00	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	34.40	2.87	2.09	1.56	0.52	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	53.26	8.23	5.94	2.51	1.60	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	44.24	2.60	2.43	3.12	1.21	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	23.80	0.00	0.37	0.73	0.18	0.00	0.55
colon carcinoma cell line:COLO-320	10420-106C6	89.32	4.18	4.94	0.76	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	23.80	7.14	8.33	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	34.66	6.11	4.47	2.94	0.12	0.00	0.47
colon, fetal, donor1	10070-101I7	38.32	6.80	5.56	6.80	0.00	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	26.35	2.12	0.42	0.00	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	31.09	1.21	1.21	1.06	0.91	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	36.80	1.83	1.97	0.56	0.85	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	27.31	4.42	3.87	3.32	0.11	0.00	0.33
cruciate ligament, donor2	10295-104G7	14.59	0.81	0.00	3.24	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	20.06	4.82	4.82	2.41	0.00	0.00	0.00
diencephalon, adult	10193-103E4	10.32	2.88	2.16	0.96	0.24	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	74.85	1.84	0.69	0.92	2.76	6.66	3.44
ductal cell carcinoma cell line:KLM-1	10438-106E6	29.75	3.85	2.56	1.54	0.26	0.00	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	55.13	4.57	1.44	0.96	0.24	0.00	0.72
ductus deferens, adult	10196-103E7	19.93	1.99	1.00	0.50	0.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	4.32	5.76	2.88	1.44	0.00	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	44.87	8.09	4.41	3.68	0.74	0.00	2.94
dura mater, adult, donor1	10041-101F5	45.26	3.55	3.22	1.90	0.17	0.08	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	34.87	0.67	0.44	0.67	2.00	0.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	29.81	0.86	1.15	0.57	0.86	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	14.18	1.85	1.85	1.23	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	23.01	1.82	2.72	1.21	0.61	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	21.30	1.54	2.78	0.62	1.54	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	19.70	1.31	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	36.87	1.68	0.67	1.34	3.69	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	27.73	5.44	3.81	1.09	0.00	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	34.25	1.45	1.93	1.77	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	27.79	4.67	4.45	2.00	0.33	0.00	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	30.91	1.65	1.65	0.66	0.00	0.00	0.77
epididymis, adult	10197-103E8	30.14	5.02	2.30	3.98	0.42	0.00	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	9.93	1.06	1.77	1.24	0.18	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.93	0.39	0.39	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	27.00	4.19	3.15	3.28	1.05	0.00	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	36.02	3.35	4.04	4.92	1.38	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.80	3.70	3.70	3.81	1.01	0.00	0.67
esophagus, adult, pool1	10015-101C6	24.74	3.29	1.91	2.55	0.42	0.11	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	23.17	0.88	1.25	0.13	0.25	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	14.49	2.41	2.41	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	2.10	0.00	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1.49	5.95	1.49	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	5.73	2.29	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	10.20	1.46	0.00	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	31.02	5.34	4.58	2.80	0.00	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	13.98	1.92	1.28	0.51	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	9.73	2.37	0.71	0.95	0.24	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	16.89	3.19	3.85	2.35	0.28	0.00	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	49.24	4.80	3.30	1.50	0.00	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	58.61	7.95	7.95	1.65	1.28	0.00	0.46
gall bladder, adult	10198-103E9	20.28	7.97	1.45	3.38	0.00	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	20.94	4.29	2.15	5.91	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	32.12	2.99	2.99	6.72	0.75	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.10	4.44	1.27	4.22	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	16.05	2.51	0.58	0.97	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	35.25	3.44	2.13	0.49	0.33	0.00	0.49
gastric cancer cell line:GSS	10560-108A2	24.71	4.58	0.92	1.83	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	55.06	3.43	1.37	0.46	0.69	0.00	0.69
giant cell carcinoma cell line:LU65	10487-107B1	40.85	1.72	3.21	0.69	0.00	0.00	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	30.37	2.66	1.54	1.68	0.98	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	19.21	4.74	3.49	1.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	8.02	2.53	1.69	0.95	0.21	0.00	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.02	1.40	1.69	0.84	0.00	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	29.58	1.21	1.43	1.66	1.21	0.00	0.33
glioma cell line:GI-1	10413-106B8	35.73	2.64	3.22	1.76	0.88	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	18.95	3.64	2.92	4.37	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	29.05	5.61	3.66	3.17	0.24	0.00	1.71
globus pallidus, adult, donor10258	10367-105F7	26.01	4.11	6.85	4.11	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	13.86	2.13	2.13	0.53	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	12.24	2.45	2.45	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	10.88	2.88	1.28	0.32	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	27.09	0.92	0.46	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	28.35	0.00	0.46	0.91	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	17.39	1.29	0.64	0.64	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	35.93	2.87	0.00	0.00	0.00	0.00	2.87
hIPS, biol_rep2	14381-156B7	14.40	0.69	0.00	0.69	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	18.76	3.31	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	23.56	2.59	0.86	1.44	0.29	0.00	0.29
heart - mitral valve, adult	10205-103F7	8.37	2.99	1.79	5.68	0.00	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	17.78	4.97	2.88	3.14	0.26	0.00	0.78
heart - tricuspid valve, adult	10207-103F9	14.99	2.50	3.33	2.50	0.83	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	18.57	5.31	4.49	2.65	0.20	0.00	0.41
heart, adult, diseased, donor1	10051-101G6	15.76	4.26	2.55	4.26	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	7.59	3.22	0.92	1.84	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	42.00	2.67	1.54	1.54	0.31	0.10	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.06	2.16	4.01	0.93	0.00	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	33.30	1.19	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	18.23	0.44	0.88	0.55	0.55	0.00	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.36	1.21	0.61	0.24	0.36	0.00	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	25.26	0.91	1.01	0.20	0.51	0.00	0.61
hepatoma cell line:Li-7	10484-107A7	32.25	1.33	1.89	1.00	0.22	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	52.86	2.51	1.31	1.01	3.42	0.30	0.80
hippocampus - adult, donor10196	10169-103B7	17.03	0.95	4.73	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	21.63	3.06	1.84	3.88	0.20	0.00	1.63
hippocampus, adult, donor10258	10374-105G5	9.46	3.49	3.98	1.99	0.00	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	11.28	1.76	1.06	0.70	0.00	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	51.88	1.22	3.05	1.22	6.10	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	32.40	0.98	0.79	0.39	4.12	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	35.29	1.02	1.78	0.76	2.79	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	38.91	1.69	3.38	0.00	1.69	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	54.48	1.29	2.32	0.52	2.07	0.00	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	64.15	2.28	1.90	0.76	2.66	0.00	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	33.28	1.75	1.46	0.58	2.92	0.00	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	40.72	1.51	1.94	0.43	2.15	0.00	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	22.10	1.67	2.50	0.42	0.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	30.07	1.42	1.18	0.24	0.24	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	27.00	1.13	0.96	0.32	0.80	0.00	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	27.61	0.67	2.02	0.67	2.02	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.76	0.31	0.31	0.47	4.07	0.00	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	29.97	0.49	0.00	0.98	2.95	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	48.00	1.75	1.75	0.00	9.60	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	58.99	1.53	0.95	0.38	1.72	0.00	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	52.33	0.44	2.62	1.31	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	80.96	1.00	1.50	2.00	1.50	0.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	53.31	1.51	2.07	0.19	0.94	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	58.20	2.73	4.09	0.91	1.82	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	46.99	1.57	1.57	0.63	0.63	0.00	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	33.15	0.33	0.65	0.49	0.16	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	33.10	0.58	0.58	0.29	0.00	0.00	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	26.01	0.60	0.90	0.00	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	35.66	0.55	1.11	0.37	3.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	35.95	1.43	2.57	0.00	1.43	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	51.86	2.04	1.63	0.82	3.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	61.97	1.06	2.11	0.35	0.35	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	50.04	0.63	2.53	0.32	0.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	52.96	1.82	0.61	0.30	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	43.44	1.03	2.07	2.07	0.52	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.19	1.33	0.66	0.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	26.17	0.51	1.03	0.26	1.54	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	28.38	1.02	1.02	0.26	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	29.53	3.79	1.51	0.76	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	21.51	1.34	1.01	0.00	0.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	32.84	0.72	0.48	0.24	2.42	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	49.47	2.23	0.89	0.00	3.12	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	41.95	0.00	1.46	0.00	1.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	60.21	0.92	2.44	0.00	0.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	422.92	0.00	0.00	0.00	9.76	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	88.69	1.32	2.65	0.66	1.65	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.45	1.09	0.00	0.00	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	44.15	1.81	2.17	0.36	0.72	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	30.96	1.42	0.71	0.36	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	0.00	2.39	0.00	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	42.39	0.95	1.63	0.27	0.14	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	28.29	1.08	1.08	0.00	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	33.66	3.87	2.18	2.42	0.24	0.24	0.48
immature langerhans cells, donor2	11905-125F6	14.26	2.38	3.96	1.58	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	15.14	2.74	3.22	1.89	0.19	0.00	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	14.96	0.00	1.63	0.65	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	32.34	4.21	4.31	5.51	0.40	0.10	0.30
kidney, fetal, pool1	10045-101F9	24.40	2.97	2.12	2.83	0.50	0.00	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	11.22	1.14	0.71	0.43	0.14	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.17	1.52	1.52	0.55	0.28	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	30.09	5.14	4.04	2.39	0.55	0.00	0.00
left atrium, adult, donor1	10079-102A7	25.06	8.17	1.63	5.45	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	16.18	8.60	3.03	4.05	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	10.67	0.82	0.55	0.82	0.27	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	15.45	1.80	1.44	2.87	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	15.76	1.63	0.54	1.63	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	18.45	2.67	1.70	0.49	0.00	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	15.68	0.00	0.00	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	30.70	3.31	1.77	2.13	0.12	0.00	0.71
liposarcoma cell line:KMLS-1	10782-110G8	19.06	3.28	2.66	1.41	0.47	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	9.87	2.07	0.49	1.10	0.24	0.00	0.00
liver, adult, pool1	10018-101C9	18.80	2.43	1.46	2.11	0.00	0.00	0.16
liver, fetal, pool1	10086-102B5	3.76	1.88	0.94	0.00	0.00	0.94	2.82
locus coeruleus - adult, donor10196	10182-103D2	12.69	3.50	2.62	2.19	0.15	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	23.99	2.21	2.03	3.14	0.18	0.00	0.74
locus coeruleus, adult, donor10258	10375-105G6	13.54	5.36	3.67	3.10	0.00	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	31.97	2.10	2.10	2.52	1.26	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	13.42	1.38	1.11	1.38	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	28.96	2.07	2.76	4.14	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	17.00	2.77	3.30	1.19	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	33.90	5.43	2.24	4.02	0.12	0.00	0.12
lung, fetal, donor1	10068-101I5	89.62	6.28	2.28	1.43	0.57	0.00	1.14
lung, right lower lobe, adult, donor1	10075-102A3	24.74	5.96	2.29	6.42	2.29	0.00	1.37
lymph node, adult, donor1	10077-102A5	42.13	3.79	2.84	0.95	3.79	1.89	1.89
lymphangiectasia cell line:DS-1	10727-110A7	39.45	5.70	3.07	2.63	0.22	0.00	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.71	0.91	0.75	0.15	9.51	11.47	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	27.18	0.85	3.40	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	27.97	7.99	3.11	6.22	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	29.68	7.68	2.70	4.15	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	84.39	8.30	7.35	7.59	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	88.44	8.69	3.16	3.42	0.79	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	58.37	2.86	4.29	0.95	0.71	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	10.15	1.13	2.26	3.38	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	16.74	2.57	2.02	2.76	0.18	0.00	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	9.21	3.49	2.86	0.64	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	28.15	2.99	1.28	2.13	1.28	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	14.68	2.70	3.88	3.04	0.00	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	17.61	3.61	3.40	5.52	0.00	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	0.00	0.00	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00	0.00	0.00	0.00	0.00	200.95
medial temporal gyrus, newborn, donor10223	10353-105E2	15.08	1.44	2.51	1.08	1.79	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	23.36	4.54	6.49	5.19	0.00	0.00	2.60
medulla oblongata, adult, donor10252	10155-103A2	34.52	3.41	2.79	4.95	0.15	0.00	2.17
medulla oblongata, adult, pool1	10038-101F2	16.24	3.59	3.43	2.29	0.41	0.00	0.24
medulla oblongata, newborn, donor10223	10361-105F1	21.53	2.43	1.74	1.74	2.08	0.00	1.04
medulloblastoma cell line:D283 Med	10838-111E1	153.00	3.99	1.11	0.89	0.00	0.00	2.21
medulloblastoma cell line:ONS-76	10759-110E3	14.92	2.81	2.20	1.59	0.37	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	25.87	2.01	1.15	0.14	0.00	0.00	0.29
melanoma cell line:G-361	10465-106H6	26.60	1.09	2.44	1.09	0.27	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	21.35	5.61	2.53	0.90	0.36	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	35.25	1.76	5.29	0.00	1.76	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	19.18	2.33	1.04	1.04	1.30	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	23.32	3.84	1.99	1.23	0.15	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	25.09	2.36	1.09	0.91	0.18	0.00	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.99	4.97	2.48	0.83	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.09	2.81	1.83	0.56	0.28	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	21.57	1.93	0.58	0.96	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.76	3.47	2.78	0.00	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	26.43	5.66	1.54	1.03	0.17	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.93	2.19	2.99	0.69	0.00	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.26	2.12	0.53	0.27	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	16.88	1.89	1.08	0.68	0.00	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	20.49	1.28	1.00	0.85	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	26.02	2.96	0.66	0.33	0.33	0.00	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	27.81	2.21	2.21	0.83	0.00	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.01	2.09	1.75	0.70	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	34.10	3.06	2.04	1.22	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.46	1.44	1.44	1.08	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.72	3.00	3.62	1.76	0.00	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.78	1.14	2.51	0.91	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	44.47	2.52	2.94	0.00	0.00	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	19.73	2.24	1.20	1.20	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	31.77	2.19	3.24	0.96	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	49.70	5.15	2.58	0.37	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.31	1.72	2.86	1.14	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.21	3.37	2.95	0.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	26.94	2.74	0.00	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	23.28	2.05	2.05	1.79	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	23.56	1.83	3.14	1.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.18	0.92	2.16	0.92	0.00	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	22.59	0.94	1.41	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	25.72	1.69	2.03	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.79	1.57	1.96	1.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.00	1.39	4.17	2.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	22.21	2.88	1.73	1.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.42	1.34	1.78	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.99	3.36	0.96	0.96	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.20	2.20	0.73	1.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.14	0.67	1.01	1.34	0.00	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	1.23	1.23	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.90	1.29	0.43	0.43	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	0.00	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	18.19	2.60	2.27	1.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	4.36	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.32	1.60	1.07	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.17	3.27	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	18.66	2.33	1.55	1.94	0.00	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	25.18	2.10	4.20	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	13.91	2.98	0.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.23	1.19	2.37	1.19	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	1.22	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	16.47	2.53	0.63	1.90	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	26.56	3.10	1.72	1.38	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	4.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	43.60	2.44	0.41	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	51.64	4.77	3.18	2.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	44.80	3.54	0.59	1.77	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	51.12	3.43	2.49	0.94	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	36.09	6.68	1.34	4.01	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	56.77	3.55	2.37	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	5.14	0.00	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	62.64	6.20	1.38	1.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	76.70	8.91	4.45	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	77.38	4.49	1.12	2.24	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	58.52	5.09	4.45	1.91	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	66.09	4.84	4.03	2.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	61.06	8.72	2.18	4.36	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	49.42	8.87	1.27	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	76.47	15.17	3.03	1.21	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	117.49	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	84.84	6.59	3.29	4.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	54.37	3.97	2.38	1.39	0.00	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	40.56	4.22	1.62	1.30	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	33.61	5.09	1.02	4.07	0.00	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	2.32	0.00	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	27.88	12.05	5.43	4.96	0.47	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	12.51	0.70	0.93	0.46	0.93	0.00	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	0.00	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	21.17	1.64	2.06	1.64	1.03	0.00	0.10
mesothelioma cell line:Mero-25	10850-111F4	19.52	2.27	0.45	1.82	1.59	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	11.98	1.71	0.98	1.96	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	14.61	1.11	0.66	0.89	0.66	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	14.19	0.79	0.79	0.79	0.00	0.00	0.53
mesothelioma cell line:Mero-83	10854-111F8	30.13	3.92	2.55	1.19	0.34	0.00	0.51
mesothelioma cell line:Mero-84	10855-111F9	2.02	10.36	0.25	11.88	0.51	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	12.22	1.66	0.41	2.07	0.41	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	9.61	1.33	0.83	0.66	0.00	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	15.75	0.72	0.36	0.18	0.90	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	13.32	1.54	1.88	1.20	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	32.57	5.34	2.29	1.78	0.25	0.00	0.51
mesothelioma cell line:No36	10857-111G2	10.44	1.63	0.98	0.98	0.65	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	23.84	1.35	0.81	0.81	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	24.57	1.92	1.54	1.15	0.38	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	16.36	1.95	1.22	3.54	0.49	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	34.82	2.51	1.26	0.90	0.72	0.00	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	23.83	3.26	2.29	1.31	0.33	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.29	1.27	0.85	1.91	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.98	6.22	5.30	0.69	0.23	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	11.42	3.04	1.52	0.57	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	99.23	4.44	6.84	1.48	1.85	0.00	1.85
myeloma cell line:PCM6	10474-106I6	18.19	4.94	3.16	0.79	0.40	0.59	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	4.06	3.04	1.52	1.52	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.16	4.32	1.77	0.98	0.00	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	36.77	6.80	4.01	1.89	0.45	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	44.42	6.84	5.74	2.06	0.29	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	32.57	2.21	3.31	0.55	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	63.04	5.06	4.83	1.38	3.91	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	34.42	3.37	3.55	2.25	1.12	0.00	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	34.16	1.48	1.05	0.42	0.42	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	65.41	6.71	2.24	2.42	0.56	0.00	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	53.38	4.03	3.08	1.90	0.00	0.00	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	38.33	4.75	2.69	2.69	0.16	0.00	2.38
neuroectodermal tumor cell line:TASK1	10774-110F9	42.06	3.82	1.61	1.01	1.81	0.00	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.72	1.91	1.91	1.91	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	9.05	2.66	0.80	0.27	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	53.78	1.69	2.54	1.35	9.47	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	46.43	4.00	0.80	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.71	0.96	1.92	0.32	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	28.90	2.10	2.63	1.31	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	16.97	2.34	3.56	2.25	0.00	0.00	0.47
occipital cortex - adult, donor10196	10172-103C1	18.54	4.12	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	20.40	3.76	2.42	3.49	0.00	0.00	1.34
occipital cortex, newborn, donor10223	10355-105E4	14.19	1.46	3.64	1.46	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	10.50	3.41	4.20	2.36	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	27.03	4.72	8.15	1.72	0.00	0.00	2.15
occipital pole, adult, pool1	10036-101E9	8.36	1.89	1.58	0.95	0.00	0.00	0.00
olfactory region, adult	10195-103E6	9.36	2.67	3.44	1.91	0.19	0.00	0.38
optic nerve, donor1	10277-104E7	14.01	2.00	2.00	6.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	41.58	4.10	4.33	3.30	0.34	0.11	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	30.50	0.96	2.47	0.14	1.92	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	35.90	2.88	1.52	2.20	0.17	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	50.82	4.97	2.19	1.04	0.58	0.00	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	14.40	2.94	2.35	2.06	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	25.23	0.93	0.00	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	47.08	3.82	2.33	4.88	0.64	0.00	0.42
ovary, adult, pool1	10020-101D2	18.43	2.45	1.48	2.88	0.17	0.00	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.78	2.20	2.20	0.92	0.37	0.00	0.18
pancreas, adult, donor1	10049-101G4	18.81	4.70	2.82	0.00	0.00	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	36.90	1.12	1.96	0.56	0.00	0.00	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	15.33	0.85	0.85	0.68	0.00	0.00	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	26.16	3.48	1.82	1.16	0.83	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	13.27	2.38	4.03	1.83	0.09	0.00	0.09
parietal cortex, adult, donor10258	10373-105G4	13.95	0.73	0.00	3.67	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	11.29	2.82	2.82	3.76	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	21.95	1.71	2.85	2.28	0.29	0.00	1.14
parietal lobe, adult, pool1	10034-101E7	12.42	2.47	2.03	2.11	0.00	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	33.94	4.85	8.73	1.94	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	13.46	0.75	2.24	1.50	1.12	0.00	0.75
parotid gland, adult	10199-103F1	32.68	5.55	3.70	1.23	0.00	0.00	0.00
penis, adult	10200-103F2	17.72	4.83	2.15	2.69	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	99.29	6.88	7.44	6.88	0.93	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	16.90	2.48	1.17	1.02	2.04	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	7.74	1.29	3.87	2.58	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	35.53	5.92	5.33	2.96	1.18	0.00	2.37
pineal gland, adult, donor10258	10377-105G8	13.80	4.39	1.88	1.88	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	26.31	12.14	13.15	3.04	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	56.29	6.25	3.13	5.21	1.04	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	27.24	3.40	6.81	4.26	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	38.16	2.90	2.04	2.26	0.54	0.22	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	95.88	3.58	1.19	0.93	1.59	3.71	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.03	5.45	2.96	8.40	0.00	0.00	0.16
pons, adult, pool1	10033-101E6	16.96	2.93	3.96	1.81	0.09	0.00	0.43
postcentral gyrus, adult, pool1	10032-101E5	11.33	1.39	2.53	1.39	0.09	0.00	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	2.09	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	16.46	3.06	2.62	1.02	0.00	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	17.06	2.36	1.63	0.36	0.54	0.00	0.54
prostate, adult, pool1	10022-101D4	27.30	4.72	2.09	2.54	0.73	0.00	0.18
putamen, adult, donor10196	10176-103C5	18.41	3.78	4.72	2.83	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	21.57	0.00	1.96	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	2.19	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	15.70	3.87	4.11	1.93	0.00	0.24	0.72
putamen, newborn, donor10223	10365-105F5	40.48	3.00	3.75	4.50	0.75	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	54.99	4.95	2.33	3.20	0.87	0.00	0.00
rectum, fetal, donor1	10067-101I4	31.99	4.17	2.78	2.78	1.39	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	34.13	4.24	4.03	3.60	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	43.49	5.38	3.31	4.56	2.07	0.00	0.41
retina, adult, pool1	10030-101E3	29.02	3.78	3.58	4.67	0.00	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	63.65	1.30	2.34	0.52	1.04	0.00	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	14.75	2.09	0.86	1.23	0.25	0.00	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	27.28	0.28	1.12	0.00	0.00	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.91	0.76	3.03	1.52	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	21.53	3.56	2.27	0.97	0.16	0.00	0.81
salivary acinar cells, donor2	11772-123I8	21.48	5.37	1.79	1.93	0.28	0.00	0.41
salivary acinar cells, donor3	11773-123I9	9.93	1.32	1.99	2.65	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	37.75	4.00	4.00	2.29	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.43	3.79	3.29	1.35	0.84	0.00	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.63	2.94	3.06	1.41	0.35	0.00	0.12
seminal vesicle, adult	10201-103F3	16.40	3.70	4.23	3.70	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.22	2.67	1.94	3.16	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	21.89	2.26	1.76	2.26	0.25	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	4.01	3.01	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.75	1.07	1.21	0.67	0.13	0.00	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	32.16	2.98	2.32	1.22	0.55	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	27.48	4.39	3.48	1.81	0.13	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	9.93	4.26	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	15.23	2.64	1.92	2.28	0.12	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	17.09	1.01	1.01	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	6.79	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	25.25	3.79	3.16	3.79	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	25.68	2.00	2.33	1.33	0.67	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	49.80	1.26	1.26	0.00	0.32	0.00	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	30.84	7.13	5.59	0.77	0.00	0.00	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	37.42	1.65	2.80	0.66	0.00	0.00	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	81.23	6.11	4.02	1.45	1.29	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	44.46	1.96	1.31	0.87	0.22	0.00	0.44
small intestine, adult, pool1	10024-101D6	45.03	10.75	7.88	2.39	0.48	0.12	1.31
small intestine, fetal, donor1	10064-101I1	33.91	4.91	6.63	3.44	0.98	0.25	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	53.85	6.67	4.62	4.10	0.00	0.00	2.56
smooth muscle, adult, pool1	10048-101G3	24.29	3.88	0.78	2.33	0.00	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	28.41	3.48	1.61	0.27	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	26.84	3.90	4.36	3.44	0.46	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	59.93	7.89	3.15	2.76	0.79	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	36.67	8.99	6.23	2.08	0.00	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	20.73	3.05	2.44	3.66	0.61	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	30.77	2.30	4.59	1.84	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.55	3.58	2.09	1.05	0.00	0.00	0.15
spleen, adult, pool1	10025-101D7	61.01	2.31	1.76	2.20	7.60	2.97	2.31
spleen, fetal, pool1	10044-101F8	52.76	3.73	2.15	1.51	4.05	3.50	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	50.10	1.86	2.48	0.52	0.31	19.15	1.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	39.11	6.46	3.61	2.09	0.00	0.00	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.45	2.10	2.10	2.45	0.00	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.20	2.74	1.56	0.39	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	27.80	5.63	3.04	4.16	0.00	0.00	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	33.04	7.20	3.39	1.27	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	10.58	0.85	0.42	0.42	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	23.50	3.20	0.00	5.34	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	21.65	6.27	3.42	4.56	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	108.55
substantia nigra, adult, donor10252	10158-103A5	31.78	4.15	1.45	4.36	0.62	0.00	1.25
substantia nigra, adult, donor10258	10371-105G2	15.52	4.14	4.14	1.03	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	27.56	2.83	2.12	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	28.20	2.52	3.21	0.46	0.23	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	9.66	2.29	2.71	1.02	0.08	0.00	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	27.07	5.70	5.70	2.14	0.00	0.00	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.58	1.76	2.20	0.00	0.44	0.00	1.32
tenocyte, donor1	11763-123H8	13.27	4.19	2.09	2.09	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	35.48	4.20	2.29	2.67	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	15.20	1.48	1.85	0.74	0.74	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	45.21	1.87	1.02	1.02	4.59	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	34.53	1.39	1.39	0.92	0.00	0.00	0.62
teratocarcinoma cell line:PA-1	10807-111A6	34.41	1.55	2.32	0.46	0.46	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	26.53	1.14	0.89	0.76	0.51	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	52.57	1.13	1.89	0.00	1.89	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	88.78	3.27	0.98	1.20	0.55	0.00	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	145.26	4.56	2.93	2.28	0.00	0.00	1.95
testis, adult, pool1	10026-101D8	31.67	1.83	2.25	1.83	0.43	0.11	0.00
testis, adult, pool2	10096-102C6	18.49	2.26	0.90	1.35	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	24.29	2.21	5.52	2.21	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	30.79	2.34	2.50	4.84	0.00	0.00	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	24.63	6.16	4.62	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	13.34	4.12	3.13	2.47	0.00	0.00	0.49
thalamus, newborn, donor10223	10366-105F6	16.68	1.73	1.15	0.00	0.00	0.00	1.15
throat, adult	10209-103G2	27.96	3.99	2.50	4.24	0.00	0.50	0.50
throat, fetal, donor1	10061-101H7	23.77	2.74	2.44	2.44	0.30	0.00	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	25.24	0.40	2.38	1.99	2.19	0.00	0.20
thymus, adult, pool1	10027-101D9	44.34	3.28	2.58	3.08	3.08	0.10	0.60
thymus, fetal, pool1	10043-101F7	72.11	5.30	4.68	4.36	6.44	0.62	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.39	3.46	3.06	1.20	0.00	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	20.12	4.89	2.37	2.37	0.42	0.00	0.14
thyroid, adult, pool1	10028-101E1	31.45	4.57	2.89	4.01	0.28	0.00	0.19
thyroid, fetal, donor1	10060-101H6	17.14	1.85	2.64	3.16	0.26	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	3.08	6.16	0.00	3.08	0.00	3.08
tongue, adult	10203-103F5	14.19	3.49	2.09	2.33	0.00	0.23	0.00
tongue, fetal, donor1	10059-101H5	31.92	7.49	1.58	3.15	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	48.59	4.31	2.91	2.80	4.31	3.81	0.60
trachea, adult, pool1	10029-101E2	29.37	3.68	3.03	2.04	1.96	0.25	0.00
trachea, fetal, donor1	10058-101H4	17.70	2.31	0.77	1.92	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.63	2.48	2.13	0.00	0.00	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	28.17	1.22	1.32	0.71	0.00	0.00	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	63.77	4.54	5.64	2.66	2.82	0.00	0.63
tridermal teratoma cell line:HGRT	10694-109G1	5.71	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.58	4.66	2.37	1.86	0.25	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	4.17	0.00	2.09	4.17	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	34.13	2.90	0.68	2.73	0.00	0.00	0.34
uterus, fetal, donor1	10055-101H1	18.94	3.58	2.56	2.05	0.51	0.00	0.00
vagina, adult	10204-103F6	16.80	1.29	1.29	3.88	0.00	0.00	0.65
vein, adult	10191-103E2	37.48	5.48	3.29	2.41	7.45	0.88	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	68.36	4.01	0.53	0.80	10.15	9.61	4.01